세계의 동반 진단 기기 시장 2020-2024

■ 영문 제목 : Global Companion Diagnostics Market 2020-2024

Technavio가 발행한 조사보고서이며, 코드는 IRTNTR46416 입니다.■ 상품코드 : IRTNTR46416
■ 조사/발행회사 : Technavio
■ 발행일 : 2020년 12월
■ 페이지수 : 약120
■ 작성언어 : 영어
■ 보고서 형태 : PDF
■ 납품 방식 : E메일
■ 조사대상 지역 : 세계
■ 산업 분야 : 의료
■ 판매가격 / 옵션 (부가세별도)
Single User (1명 열람용)USD2,500 ⇒환산₩2,750,000견적의뢰/주문/질문
Five User (5명 열람용)USD3,000 ⇒환산₩3,300,000견적의뢰/주문/질문
Enterprise License (동일기업내 공유가능)USD4,000 ⇒환산₩4,400,000견적의뢰/구입/질문
가격옵션 설명
- 지불하실 금액은 상기 원화금액에 부가세(10%)를 더한 금액입니다.
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제이며, 세금계산서 발행 가능합니다.
■ 보고서 개요

Global Companion Diagnostics Market 2020-2024Technavio has been monitoring the companion diagnostics market and it is poised to grow by $ 5.74 bn during 2020-2024 progressing at a CAGR of 26% during the forecast period. Our report on companion diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rising use of personalized medicine, increased industry collaborations, and growing investments in life sciences sector. In addition, rising use of personalized medicine is anticipated to boost the growth of the market as well.
The companion diagnostics market analysis includes end-user segment and geographical landscapes.

Technavio’s companion diagnostics market is segmented as below:
By End-user
• Life science
• Health centers
• Others

By Geographic Landscapes
• North America
• Europe
• Asia
• ROW

This study identifies the rising occurrence of breast cancer as one of the prime reasons driving the companion diagnostics market growth during the next few years. Also, increase in product approvals to treat cancer and growing importance for promotional activities will lead to sizable demand in the market.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on companion diagnostics market covers the following areas:
• Companion diagnostics market sizing
• Companion diagnostics market forecast
• Companion diagnostics market industry analysis

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading companion diagnostics market vendors that include Abbott Laboratories, Agilent Technologies Inc., bioMérieux SA, F. Hoffmann-La Roche Ltd., Illumina Inc., Myriad Genetics Inc., QIAGEN NV, Siemens Healthineers AG, Sysmex Corp., Thermo Fisher Scientific Inc. Also, the companion diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – www.technavio.com/report/companion-diagnostics-market-industry-analysis
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

■ 보고서 목차

• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2019
o Market outlook: Forecast for 2019 – 2024
• Five Forces Analysis
o Five Forces Summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by End-user
o Market segments
o Comparison by End-user
o Life science – Market size and forecast 2019-2024
o Health centers – Market size and forecast 2019-2024
o Others – Market size and forecast 2019-2024
o Market opportunity by End-user
• Customer landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America – Market size and forecast 2019-2024
o Europe – Market size and forecast 2019-2024
o Asia – Market size and forecast 2019-2024
o ROW – Market size and forecast 2019-2024
o Key leading countries
o Market opportunity by geography
o Volume drivers – Demand led growth
o Market challenges
o Market trends
• Vendor Landscape
o Overview
o Vendor landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Abbott Laboratories
o Agilent Technologies Inc.
o bioMérieux SA
o F. Hoffmann-La Roche Ltd.
o Illumina Inc.
o Myriad Genetics Inc.
o QIAGEN NV
o Siemens Healthineers AG
o Sysmex Corp.
o Thermo Fisher Scientific Inc.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations

Exhibit
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global – Market size and forecast 2019 – 2024 ($ million)
• 13: Global market: Year-over-year growth 2019 – 2024 (%)
• 14: Five forces analysis 2019 & 2024
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition – Five forces 2019
• 21: End user – Market share 2019-2024 (%)
• 22: Comparison by End user
• 23: Life science – Market size and forecast 2019-2024 ($ million)
• 24: Life science – Year-over-year growth 2019-2024 (%)
• 25: Health centers – Market size and forecast 2019-2024 ($ million)
• 26: Health centers – Year-over-year growth 2019-2024 (%)
• 27: Others – Market size and forecast 2019-2024 ($ million)
• 28: Others – Year-over-year growth 2019-2024 (%)
• 29: Market opportunity by End user
• 30: Customer landscape
• 31: Market share by geography 2019-2024 (%)
• 32: Geographic comparison
• 33: North America – Market size and forecast 2019-2024 ($ million)
• 34: North America – Year-over-year growth 2019-2024 (%)
• 35: Europe – Market size and forecast 2019-2024 ($ million)
• 36: Europe – Year-over-year growth 2019-2024 (%)
• 37: Asia – Market size and forecast 2019-2024 ($ million)
• 38: Asia – Year-over-year growth 2019-2024 (%)
• 39: ROW – Market size and forecast 2019-2024 ($ million)
• 40: ROW – Year-over-year growth 2019-2024 (%)
• 41: Key leading countries
• 42: Market opportunity by geography ($ million)
• 43: Impact of drivers and challenges
• 44: Vendor landscape
• 45: Landscape disruption
• 46: Industry risks
• 47: Vendors covered
• 48: Market positioning of vendors
• 49: Abbott Laboratories – Overview
• 50: Abbott Laboratories – Business segments
• 51: Abbott Laboratories – Key offerings
• 52: Abbott Laboratories – Key customers
• 53: Abbott Laboratories – Segment focus
• 54: Agilent Technologies Inc. – Overview
• 55: Agilent Technologies Inc. – Business segments
• 56: Agilent Technologies Inc. – Key offerings
• 57: Agilent Technologies Inc. – Key customers
• 58: Agilent Technologies Inc. – Segment focus
• 59: bioMérieux SA – Overview
• 60: bioMérieux SA – Business segments
• 61: bioMérieux SA – Key offerings
• 62: bioMérieux SA – Key customers
• 63: bioMérieux SA – Segment focus
• 64: F. Hoffmann-La Roche Ltd. – Overview
• 65: F. Hoffmann-La Roche Ltd. – Business segments
• 66: F. Hoffmann-La Roche Ltd. – Key offerings
• 67: F. Hoffmann-La Roche Ltd. – Key customers
• 68: F. Hoffmann-La Roche Ltd. – Segment focus
• 69: Illumina Inc. – Overview
• 70: Illumina Inc. – Product and service
• 71: Illumina Inc. – Key offerings
• 72: Illumina Inc. – Key customers
• 73: Illumina Inc. – Segment focus
• 74: Myriad Genetics Inc. – Overview
• 75: Myriad Genetics Inc. – Business segments
• 76: Myriad Genetics Inc. – Key offerings
• 77: Myriad Genetics Inc. – Key customers
• 78: Myriad Genetics Inc. – Segment focus
• 79: QIAGEN NV – Overview
• 80: QIAGEN NV – Business segments
• 81: QIAGEN NV – Key offerings
• 82: QIAGEN NV – Key customers
• 83: QIAGEN NV – Segment focus
• 84: Siemens Healthineers AG – Overview
• 85: Siemens Healthineers AG – Business segments
• 86: Siemens Healthineers AG – Key offerings
• 87: Siemens Healthineers AG – Key customers
• 88: Siemens Healthineers AG – Segment focus
• 89: Sysmex Corp. – Overview
• 90: Sysmex Corp. – Product and service
• 91: Sysmex Corp. – Key offerings
• 92: Sysmex Corp. – Key customers
• 93: Sysmex Corp. – Segment focus
• 94: Thermo Fisher Scientific Inc. – Overview
• 95: Thermo Fisher Scientific Inc. – Business segments
• 96: Thermo Fisher Scientific Inc. – Key offerings
• 97: Thermo Fisher Scientific Inc. – Key customers
• 98: Thermo Fisher Scientific Inc. – Segment focus
• 99: Currency conversion rates for US$
• 100: Research Methodology
• 101: Validation techniques employed for market sizing
• 102: Information sources
• 103: List of abbreviations



■ 기재된 기업 리스트

Abbott Laboratories, Agilent Technologies Inc., bioMérieux SA, F. Hoffmann-La Roche Ltd., Illumina Inc., Myriad Genetics Inc., QIAGEN NV, Siemens Healthineers AG, Sysmex Corp., Thermo Fisher Scientific Inc.
※본 조사보고서 [세계의 동반 진단 기기 시장 2020-2024] (코드 : IRTNTR46416) 판매에 관한 면책사항을 반드시 확인하세요.
※본 조사보고서 [세계의 동반 진단 기기 시장 2020-2024] 에 대해서 E메일 문의는 여기를 클릭하세요.